Showing results (1-10 of 135) with videos related to
Sort By:
Pageof 14
Nucleic Acids Research|March 18, 2020
Ectopic RNF168 expression promotes break-induced replication-like DNA synthesis at stalled replication forksJohn J Krais, Neil JohnsonCancer Research|August 5, 2020
BRCA1 Mutations in Cancer: Coordinating Deficiencies in Homologous Recombination with TumorigenesisJohn J Krais, Neil JohnsonNature Communications|August 19, 2021
RNF168-mediated localization of BARD1 recruits the BRCA1-PALB2 complex to DNA damageJohn J Krais, Yifan Wang, Pooja Patel, et al.Cancer Biology & Therapy|April 2, 2019
Targeted blockade of HSP90 impairs DNA-damage response proteins and increases the sensitivity of ovarian carcinoma cells to PARP inhibitionRashid Gabbasov, I Daniel Benrubi, Shane W O'Brien, et al.Cancer Research|March 28, 2020
RNF168-Mediated Ubiquitin Signaling Inhibits the Viability of BRCA1-Null CancersJohn J Krais, Yifan Wang, Andrea J Bernhardy, et al.Plos One|October 8, 2013
Purine nucleoside phosphorylase targeted by annexin v to breast cancer vasculature for enzyme prodrug therapyJohn J Krais, Olivier De Crescenzo, Roger G HarrisonGenome Medicine|May 26, 2025
DNA repair and the contribution to chemotherapy resistanceKsenija Nesic, Phoebe Parker, Elizabeth M Swisher, et al.The Journal of Clinical Investigation|July 26, 2016
RING domain-deficient BRCA1 promotes PARP inhibitor and platinum resistanceYifan Wang, John J Krais, Andrea J Bernhardy, et al.Nature Communications|August 14, 2024
Structural basis for a Polθ helicase small-molecule inhibitor revealed by cryo-EMFumiaki Ito, Ziyuan Li, Leonid Minakhin, et al.The Australian & New Zealand Journal of Obstetrics & Gynaecology|April 7, 2011
Metformin is a reasonable first-line treatment option for non-obese women with infertility related to anovulatory polycystic ovary syndrome--a meta-analysis of randomised trialsNeil JohnsonPageof 14